Please login to the form below

Not currently logged in
Email:
Password:

GSK strikes deal with Dr. Reddy's

GSK has entered into an agreement with Dr. Reddy's Laboratories to develop and market selected products across an extensive number of emerging markets, excluding India

GlaxoSmithKline (GSK) has entered into an agreement with Dr. Reddy's Laboratories to develop and market selected products across an extensive number of emerging markets, excluding India.

Under the agreement, GSK will gain exclusive access to Dr. Reddy's portfolio and future pipeline of more than 100 branded pharmaceuticals in fast growing therapeutic segments such as cardiovascular, diabetes, oncology, gastroenterology and pain management.

The products will be manufactured by Dr. Reddy's and licensed and supplied by GSK in various countries in Africa, the Middle East, Asia Pacific and Latin America.

In certain markets, products will be co-marketed by GSK and Dr. Reddy's. Under the terms of the agreement, revenues will be reported by GSK and shared with Dr. Reddy's as per the agreed terms.

According to GV Prasad, vice chairman and CEO, Dr. Reddy's: "We hope to take our purpose of providing affordable and innovative medicines to a much wider population through this partnership."

Abbas Hussain, president for emerging markets at GSK said: "This is another significant step forward in our strategy to grow and diversify GSK's business in emerging markets."

15th June 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics